Healthcare & Life Sciences
Intersect ENT
United Statesintersectent.com
Intersect ENT is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Intersect ENT
Based in the United States, Intersect ENT is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Intersect ENT develops and commercializes minimally invasive medical devices designed to deliver drugs for the treatment of ear, nose, and throat conditions.
Explore Intersect ENT's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.